药明康德大跌3.2%！易方达基金旗下1只基金持有

Core Viewpoint - WuXi AppTec's stock experienced a significant decline of 3.2% on April 2, 2023, indicating potential market concerns regarding the company's performance or external factors affecting investor sentiment [1]. Company Overview - WuXi AppTec was established in 2000 and is located in Wuxi, China, primarily engaged in research and experimental development [1]. - The company has a registered capital of 295,272.6521 million RMB, with GE LI (李革) serving as the legal representative [1]. Shareholder Information - E Fund's HuShen 300 Pharmaceutical ETF has entered WuXi AppTec's top ten shareholders, marking a new investment in the fourth quarter of the previous year [1]. - The ETF has recorded a year-to-date return of 3.75%, ranking 1143 out of 3442 in its category [1]. Fund Management - The fund manager for E Fund's HuShen 300 Pharmaceutical ETF is Yu Haiyan, who holds a master's degree in economics and has extensive experience in investment management [4][5].